Imai-Sumida, M., Chiyomaru, T., Majid, S., Saini, S., Nip, H., Dahiya, R., . . . Yamamura, S. (2017). Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Oncotarget.
Citação norma ChicagoImai-Sumida, Mitsuho, Takeshi Chiyomaru, Shahana Majid, Sharanjot Saini, Hannah Nip, Rajvir Dahiya, Yuichiro Tanaka, and Soichiro Yamamura. "Silibinin Suppresses Bladder Cancer Through Down-regulation of Actin Cytoskeleton and PI3K/Akt Signaling Pathways." Oncotarget 2017.
Citação norma MLAImai-Sumida, Mitsuho, et al. "Silibinin Suppresses Bladder Cancer Through Down-regulation of Actin Cytoskeleton and PI3K/Akt Signaling Pathways." Oncotarget 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.